Session Keynote Speakers

This page will be updated regularly.

Please find below an overview of all the confirmed Session Keynote Speakers, in alfabetical order. New Session Keynote Speakers will be added regularly.
At a later date the abstract titles will be added to each of the Session Keynote Speakers.

AO Research Institute

Mauro graduated in Chemistry from Lausanne University. After his Ph.D., comparing the ECM of normal and carcinomas human breast tissues, he joined the Shriners Hospital in Montreal to work on growth plate. In 1995, he was appointed as an Assist. Prof. at the McGill University and head of the Biochemistry Unit of the Orthopaedic Laboratory. In 2000, he became the head of the Musculoskeletal Regeneration Program at the AO Research Institute, and since 2020 is the Vice-Director. He received the Marshall R. Urist Award in 2015 from the ORS, and he gave the Ian Macnab lecture (Canadian ORS) in 2019.

Queensland University of Technology (QUT)

Dr Mark C Allenby is a Lecturer and Advance Queensland research fellow at Queensland University of Technology coupling tissue systems models and bioimage analyses to engineer improved medical treatments using experimental and computational approaches. Allenby is an investigator in the Herston Biofabrication Institute at the Royal Brisbane & Women's Hospital in Australia. URL:


Wake Forest Institute for Regenerative Medicine

Dr. Allickson is Chief Manufacturing Development Center Officer at Wake Forest Institute for Regenerative Medicine. She heads the clinical translation team streamlining development to create a robust pipeline of products in early phase clinical trials including cellular therapy, genetically engineered cellular therapy, tissue engineered organs and tissues and devices. Prior to the Institute, she was Vice President of R&D and Laboratory Operations for Cryo-Cell International Inc with experience in Cellular Banking and Licensure of Technology. She has a Doctorate in Health Sciences- Clinical Immunology and has 30 years of experience in clinical translation of cellular therapies and regenerative medicine products.

University of Illinois at Chicago

Dr. Alsberg is the Richard and Loan Hill Professor of Bioengineering, Orthopaedics, Pharmacology, and Mechanical & Industrial Engineering at the University of Illinois at Chicago. His lab focuses on engineering new technologies to regenerate tissues and treat diseases through development of novel biomaterials and microenvironments. He’s co-authored >130 peer reviewed papers and book chapters, and his work has been recognized with AIMBE College of Fellows membership, the Ellison Medical Foundation New Scholar in Aging Award, the Crain’s Cleveland Business Forty Under 40 Award, and Visiting Professorships in Korea and Israel.

iBET - instituto Biologia Experimental e Tecnologica

Paula Alves is the CEO of iBET and Professor at NOVA University of Lisbon; She holds a Ph.D. in Biochemical Engineering and a BSc in Biochemistry; Working in Animal Cell Technology since 1990, Professor Alves’ research integrates cell metabolism understanding with biochemical engineering for the improvement of bioprocesses for production of biopharmaceuticals, also focusing on the development of new tools for pre-clinical research. She is currently the President of the European Society for Animal Cell Technology. Published over 250 papers, 35 book chapters, supervised 36 PhD students. In 2009 she received the Scientific Merit Award from NOVA University of Lisbon.


Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)

Dr. Andrés holds a PhD in Biology from Barcelona University and had postdoctoral training in Harvard University (1991-1993) and Tufts University (1993-1995). He was appointed Assistant Professor by Tufts University (1995-2000) and joined in 1999 the Biomedicine Institute of Valencia-CSIC. In 2009, he joined the Spanish National Centre for Cardiovascular Research (CNIC), where he heads the Basic Research Department since 2015. He investigates cardiovascular disease and the role of lamin A/C in health and disease, including Hutchinson-Gilford progeria syndrome. Since 2015, he is member of the Progeria Research Foundation Medical Research Committee.

University at Buffalo

Praveen Arany received his dental degree and completed a joint PhD-Residency program at Harvard University as a Presidential Scholar. He pursued postdoctoral fellowships at IISc and NCI; served as an Assistant Clinical Investigator at NIDCR, Bethesda; and currently is Assistant Professor, Oral Biology and Biomedical Engineering, University at Buffalo. He has over 80 scientific publications incld book chapters; recipient of numerous awards; reviews and serves on editorial boards and grant agencies. He holds several leadership positions and is currently President, World Association for Photobiomodulation Therapy (WALT). His primary research focuses on the molecular mechanisms and clinical translation of Photobiomodulation therapy.

MERLN Institute, Maastricht University, Maastricht, The Netherlands

Elizabeth R. Balmayor is Assistant Professor at the MERLN Institute and associate researcher at the Mayo Clinic (Rochester/USA). She was trained as a Chemist and earned a Ph.D. in T.E.R.M. at the 3B’s research group in Portugal. 
She holds visiting professorships at the Peruvian University Cayetano-Heredia and at the UNESCO Biomaterials’ chair of the University of Havana.
Her research interests include complex biomaterial development for tissue interfaces, their interaction with stem and progenitor cells, and gene and transcript therapies for musculoskeletal regeneration. She is a pioneer in the application of chemically modified mRNA for bone healing.

Histograft, LLC

Dr. Bozo, MD,PhD, MBA is a maxillofacial surgeon, researcher in regenerative medicine field and biotechnology entrepreneur. Being involved in R&D projects in gene therapy and clinical practice in maxillofacial surgery, he co-founded “Histograft”, a Russian biotech company, with R.Deev, A.Isaev and HSCI investment in 2015. Four years later, the company brought to clinical practice the world’s first gene-activated bone substitute based on octacalcium phosphate and plasmid DNA encoding VEGFA gene. The product has been proven to be safe and effective for bone grafting and reconstructive surgery. Ongoing researches cover 3D-printing of gene-activated matrices and hydrogel platforms for non-viral gene delivery.

Nationwide Children's Hospital

Dr Breuer is the Director of the Regenerative Medicine Program at Nationwide Children's Hospital.  He is a Tenured Professor of Surgery at The Ohio State University and holds the Nationwide Endowed Chair for Surgical Research.  His research focuses on cardiovascular tissue engineering and its application in the treatment of congenital heart disease.  




Trinity College Dublin

Conor Buckley is Principal investigator (PI) in the Trinity Centre for Biomedical Engineering and the Advanced Materials and Bioengineering Research (AMBER) Centre at Trinity College Dublin, Ireland. His research focuses on novel biomaterials, biofabrication and cell-based strategies for tissue regeneration ( He has published 70 international peer reviewed journal articles and over 180 conference publications. He recently received a European Research Council Award (ERC) Consolidator award to develop personalised medicine approaches to regenerating the intervertebral disc using gene activated biomaterials and in silico predictive modelling.

Institute for Bioengineering and Biosciences, Instituto Superior Técnico, University of Lisbon, Portugal

Joaquim Cabral is a Distinguished Professor of Instituto Superior Técnico, University of Lisbon, Portugal. He was the Founding Head of Department of Bioengineering and Founding Director of the Institute for Bioengineering and Biosciences. He is graduated in Chemical Engineering with a PhD and “Habilitation” degrees in Biochemical Engineering in 1983 and 1988, respectively. He was a post-doctoral fellow at Massachusetts Institute of Technology (1983-1984). He joined IST faculty as Assistant Professor in 1984 and became Associate Professor in 1987 and Full Professor of Chemical and Biological Engineering in 1992. He has authored more than 580 publications (WoS h index 55)

University of Edinburgh

Dr Callanan is a Senior lecturer and Principal Investigator at the University of Edinburgh’s Institute for Bioengineering. The Callanan group couple the interplay between in silico modelling and cellular experimentation with focuses on scaffold and drug testing platforms. The group’s emphasis is on developing biomaterials with particular interest in human decellularized extracellular matrix materials. Dr Callanan is an author of over 60 peer-reviewed journal publications and over 170 conference proceedings. His current research utilities tissue engineering with a focus to restore tissue function in chronic diseases such as osteoarthritis, cardiac, hepatic, and renal disease.

Department of Histolgy, School of Medicine University of Granada, Spain

Antonio Campos is Full Professor of Histology at the University of Granada. He has been president of the Spanish Society of Histology, Dean and director of the National Institute of Health Carlos III where he promoted new models of biomedical investigation programs.  Promoter of tissue engineering, his group has created artificial tissues that have already been transferred to the clinic.  He has published relevant books and papers in high impact factor journals related to tissue engineering and Medical Education. Member of the Spanish Royal Academy of Medicine he has received three honoris causa doctorates in Argentina, Dominican Republic and Portugal. 

University of Genova / Endolife Srl

Ranieri Cancedda MD, Professor Emeritus of Cell Biology and past Dean of the Biotechnology School at the Genova University, Italy, also served as Head of the Regenerative Medicine Laboratory at the San-Martino teaching hospital. He is the founder of the company Endolife Srl.  First President of the European Tissue Engineering Society, now the TERMIS European Chapter, is currently a Fellow of TERMIS. He is the author of more than 350 publications (h-index 86; citations >30,000), and inventor in 9 patents. Dr. Cancedda is Field Chief Editor of Frontiers in Bioengineering and Biotechnology and Specialty Chief Editor of the TERM section.


The University of Manchester

Sarah is currently Head of the Department of Materials at The University of Manchester which is home to nearly 2,000 students and staff. In addition she is also the UK Biomedical Materials champion for The Royce Institute of a £235million UK government investment for advanced materials. She is the Director of the EPSRC CDT in Advanced Biomedical Materials. She is also a committee member for the EPSRC Advanced Materials Strategic Working Group. She is also a panel member for MRC DPFS grant funding and Specialty Chief Editor for Regenerative Technologies, a specialty section of Frontiers in Medical Technology Journal.


National Institute for Materials Science

Prof. Dr. Guoping Chen is Group Leader of Research Center for Functional Materials, National Institute for Materials Science; Professor of Department of Materials Science and Engineering, University of Tsukuba. His research interests include tissue engineering, polymeric scaffolds, biomimetic biomaterials and surface modification. He has authored more than 280 publications. He is Associate Editor of Journal of Materials Chemistry B; Editorial Boards of Journal of Bioactive and Compatible Polymers, Journal of Tissue Engineering and Regenerative Medicine, Regenerative Biomaterials, Biomedical Materials and Bioactive Materials; Advisory Board of Biomaterials Science. He has been selected Fellow of RSC in 2015 and AIMBE in 2017.

Nanyang Technological University

Dr. Sing Yian CHEW is an Associate Professor at School of Chemical & Biomedical Engineering and Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore. Her most significant contribution is in the field of scaffold-mediated delivery of gene-silencing and biomimicking physical signals for neural tissue regeneration and remyelination. Dr. Chew serves as Editorial Board member in Tissue Engineering, Frontiers in Bioengineering and Biotechnology – Biomaterials, Journal of Biomedical Materials Research Part A, Drug Delivery and Translational Research, Experimental Neurology and Journal of Tissue Engineering. In addition, Dr. Chew is an Associate Editor in ACS Applied Materials & Interfaces."


UCL, London

Dr. Coffey received his D. Phil at Oxford University and was a member of the faculty at Oxford and later the University of Sheffield as Lecturer and Senior Lecturer. He was formerly Professor and Head of Ocular Biology and Therapeutics at the Institute of Ophthalmology at University College London, where he also served as Chair of Cellular Therapies and Visual Science. Dr. Coffey has received many honors and awards, including the prestigious Estelle Doheny Living Tribute Award in 2009, Retinitis Pigmentosa International's Vision Award in 2009, the CIRM Leadership Award in 2010, and the NYSCF Roberston Prize in 2011.


Sabine Costagliola is Research Director at IRIBHM, Université Libre de Bruxelles (ULB), Belgium. She is laureate of several prizes for her contribution to thyroid and endocrine research and has a significant track record of high-profile publications in international Journals in the field. The main focus of her research is the molecular dissection of signaling mechanisms that control morphogenetic processes and gene networks involved in thyroid organogenesis with a working strategy combining several experimental models including Zebrafish and organoids.

Center of Experimental Orthopaedics, Saarland University Medical Center

Magali Cucchiarini, PhD, is a Group Leader and Vice-Director of the Center of Experimental Orthopaedics, Saarland University, Homburg/Saar, Germany. She graduated from the University of Nice-Sophia Antipolis, France (1992) and received her PhD from this University (Virology and Molecular Biology, summa cum laude, 1995). She was a senior post-doctoral fellow at the Harvard Institutes of Medicine, Boston, USA (HIV gene therapy) and at the Department of Internal Medicine, University Hospital Inselsspital, Bern, Switzerland (EU project, HCV vaccination). Her research interest is to generate cell-, gene-, and tissue engineered-based systems for musculoskeletal disorders.

University of Glasgow

Matthew became an independent researcher in 2003 securing a BBSRC Fellowship to explore mesenchymal stem cell response to nanotopography looking at self-renewal and differentiation. Appointed to a lectureship in 2008 and a Readership in 2010 he focussed more on control of mesenchymal stem cell self-renewal with nanotopography. In 2014 he became Professor of Cell Engineering at the University of Glasgow and diversified his research to include interests in low dose growth factor delivery which recently resulted in a first veterinary trial and development of a nanovibrational bioreactor that is being used to produce cells for a human trial.


University of Würzburg

Paul Dalton is a Professor in Biofabrication at the University of Würzburg. Graduating from Curtin University in Perth, Australia, he was part of a bioengineering team at the Lions Eye Institute that successfully took an artificial cornea from concept to the clinic. His career has an international perspective, with post-docs at the University of Toronto and RWTH-Aachen followed by research scientist positions at the University of Southampton and Shanghai Jiao Tong University. He invented and developed melt electrowriting as a distinct class within 3D printing with the Queensland University of Technology and has over 25 years’ experience across several disciplines.

Eindhoven University of Technology

Patricia Dankers is professor in Biomedical Materials & Chemistry. She studied chemistry in Nijmegen. Her PhD studies were performed at TU/e, on supramolecular biomaterials (2006). She worked for SupraPolix, and the University Medical Center, Groningen. Her second PhD thesis work was performed in medical sciences on kidney regenerative medicine, in Groningen (2013). She worked at Northwestern University, Chicago (2010). She climbed every step on the academic ladder, starting in 2008, ending in 2017 as full professor. She received Veni, Vidi (2008, 2017) and ERC starting, ERC PoC (2012, 2017) grants. She has recently been awarded the KNCV Gold Medal (2020).

The Ohio State University

In 1993 David Dean’s PhD thesis presented a template-based method for producing average 3D organ surface images. As a postdoctoral researcher at New York University he used average skull images as targets for surgical simulation and intra-operative guidance. Later at Case Western Reserve University he was the first person to use average surfaces to design and 3D print patient-specific cranial implants. His regenerative medicine research incorporates skeletal progenitor cells and 3D printing resorbable biomaterials. Since 2013 his research at The Ohio State University has included 3D printed NiTi for stiffness-matched skeletal fixation devices and Mg alloys for resorbable skeletal devices.


DWI - Leibniz Institute for Interactive Materials

Laura De Laporte designs Advanced Biomedical Systems that direct the interaction with cells. She studied Chemical Engineering in Ghent, where she got the tissue engineering microbe. During her PhD at Northwestern University, she engineered guiding implants for nerve regeneration, while her postdoc at EPFL in Jeffrey Hubbell’s group focused on smart hydrogels. Currently, she is a Leibniz Professor at the RWTH University and DWI-Leibniz Institute for Interactive Materials (Aachen, Germany). In her ERC Starting Grant Anisogel, her team designs low-invasive, polymeric hydrogel therapies that orient after injection to repair anisotropic tissues. In addition, dynamic hydrogels are created to study mechanobiology.

University of Washington

Dr. Cole A. DeForest is the Dan Evans Career Development Assistant Professor in the Departments of Chemical Engineering and Bioengineering at the University of Washington, where he began in 2014. His research program focuses on the development and exploitation of user-programmable biomaterials for 4D cell culture and targeted drug delivery. He has authored >50 peer-reviewed articles, including as the corresponding author for those appearing in Nature Materials, Nature Chemistry, Advanced Materials, JACS, Science Advances, and Nature Reviews Materials. His research has been supported through fellowships and grants from the NSF, NIH, HHMI, and the US Department of Education.

Julius Wolff Institut, Charité - Universitätsmedizin Berlin

Vize-Speaker Berlin Institute of Health Center for Regenerative Therapies (BCRT) Spokesperson Einstein Centre Regenerative Therapies (ECRT) & Berlin-Brandenburg School for Regenerative Therapies (BSRT). Immune-therapeutics (including a diagnostic kit identifying healing problems), expertise in mechano-biologically optimized healing, guided tissue regeneration by biomaterial scaffolds and bone formation induced by stress-relaxing scaffolds are our research foci. Findings of principles in bone healing are transferred to muscle and ligament regeneration. Immuno-therapeutic and mechano-therapeutic cues open novel avenues for regenerative therapies to restore tissue homeostasis in medical challenged patient settings.

National University of Ireland Galway

Professor Garry Duffy is Personal Professor in Anatomy & Regenerative Therapies, within the School of Medicine at the National University of Ireland Galway. He leads the Duffy Lab at NUI Galway, which is focused on developing advanced biomaterials and devices to facilitate targeted delivery and future clinical translation of cell and drug based therapeutics to treat chronic diseases.



University of Southern California

Dr. Denis Evseenko is currently an Associate Professor of Orthopaedic Surgery, Stem Cell Research and Regenerative Medicine at USC. Dr Evseenko was trained in both medicine and molecular pharmacology. His research focuses on the development of novel translational stem cell and small molecule-based approaches for prevention of arthritis and restoration of damaged articular cartilage. Dr Evseenko has been involved in translational research for over 10 years and is the author of numerous peer-reviewed research articles, presentations and patents.


University Medical Center Hamburg Eppendorf, Institute of Experimental Pharmacology and Toxicology, and German Centre for Cardiovascular Research (DZHK)

Professor Eschenhagen, MD, trained in Cardiology in Hannover and specialized in Experimental Pharmacology and Molecular Biology. He is Director of the Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg Eppendorf, Chairman German Centre for Cardiovascular Research and currently President ISHR-International. He is member of the German Academy of Science Leopoldina. His research is funded through grants from various public bodies, including an ERC AG. He published >320 papers and textbook chapters including leading pharmacology textbooks. His research focusses on molecular cardiology with a focus on heart failure, stem cells and tissue engineering, a technology he pioneered in 1994.

SP Global, Inc.

Biography will be updated soon. 









Dr. Freytes’ laboratory focuses on the design and testing of bioengineered tissues mainly composed of pluripotent stem cell derived repair cells and tissue specific extracellular matrix scaffolds. The overall goal is to develop new strategies to assemble and test bioengineered constructs capable of restoring tissue function. The major goals of the laboratory are: 1) to harness the power of tissue specific extracellular matrices to guide stem cell differentiation and/or tissue remodeling in vitro and in vivo; and 2) to understand and harness the interaction between inflammatory cells and bioengineered tissue constructs in order to improve incorporation and survival.


University of Bern

Prof Benjamin Gantenbein is heading the Tissue Engineering for Orthopedics & Mechanobiology (TOM) group at the Medical Faculty at the University of Bern (UBern). Prof Gantenbein acquired experience in modern concepts of tissue engineering and regenerative medicine. He is active in the field of tissue engineering, stem cell research ( using a wider range of bone & joint tissues. He teaches lectures on Tissue Engineering in the Biomedical Masters course at UBern and also teaches regenerative medicine at the University of Fribourg and the University of Basel.

University Medical Center Utrecht

Debby Gawlitta holds a position as Associate Professor heading her lab in the Regenerative Medicine Center Utrecht. She is affiliated with the department of 'Oral and Maxillofacial Surgery' of the University Medical Center Utrecht. Maxillofacial bone and cartilage regeneration are her research foci, with particular expertise in endochondral bone regeneration from a cartilage template and vascularized bone regeneration. Research keywords include clinical translation, biomaterials, stem/progenitor cells, bioreactors, and 3D bioprinting. Her research was supported by a.o. a prestigious Dutch Veni innovation grant and an AO startup grant.

Institute for Transfusion Medicine

Bernd Giebel received his PhD 1996 at the University zu Köln in Developmental Biology. From 1999-2008 he worked at the Heinrich-Heine-University of Düsseldorf on human hematopoietic stem and progenitor cells and set up his own group. Continuing his stem cell research, in 2008 BG moved to the University Hospital Essen and as a 2nd topic started to work with EVs.




3B's Research Group - University of Minho

Manuela E. Gomes is Associate Professor and the President of the Research Institute for Biomaterials, Biodegradable and Biomimetics (I3Bs) of the University of Minho (Portugal). Her main research topics include the development of multifunctional scaffolds and microengineered hydrogels, bioreactor design, and magnetic force based tissue engineering approaches for bone, cartilage and tendon tissue regeneration. She has been leading several national/international funded project, including the ERC Consolidator Grant (CoG) MagTendon and the EC Twinning project Achilles. She has published over 200 full papers, 45 book chapters, 8 patents and has delivered more than 50 lectures in international conferences.

University of Pennsylvania

Dr. Gottardi leads the Bioengineering and Biomaterials (Bio2) lab, collaborating on clinical and research efforts to offer engineering solutions for pediatric health, primarily treatments for airway disorders. Dr. Gottardi researches mechanisms of laryngotracheal pathologies, applies tissue engineering to improve pediatric conditions, develops new devices, and formulates controlled drug delivery systems to treat and improve patients’ lives.

Université de Montréal


May Griffith is a professor at the Dept. of Ophthalmology, Université de Montréal, located at the Maisonneuve-Rosemont Hospital Research Centre. MG is mainly recognized for leading a multinational, interdisciplinary team that achieved the world’s first successful regeneration of the human cornea, a tissue that does not regenerate itself. MG and her team used cell-free recombinant human collagen implants that stimulated the patients’ endogenous cells to regenerate a fully functional, innervated neo-cornea as an alternative to corneal transplantation using allografts. For effective clinical translation, MG has teamed-up with world renowned corneal researchers and in efforts to eradicate corneal blindness globally.

Department Biomedical Materials, Martin Luther University Halle-Wittenberg

Thomas Groth is full Professor of Biomedical Materials at Martin Luther University Halle-Wittenberg and Adjunct Professor at Sechenov University Moscow with interest on surface modification of biomaterials for making biocompatible, cell-instructive surfaces for engineering skeletal tissues and control of inflammatory response. He graduated in biology (Diploma) and obtained his PhD in biophysics at Humboldt University Berlin. He did his postdoctoral thesis (DSc) at University of Potsdam in the area of biomaterials. He was President of European Society for Artificial Organs, is Speaker of International PhD School AGRIPOLY and Board Member of Interdisciplinary Center of Materials Science at Martin Luther University.


INSERM U1229-RMeS "Regenerative Medicine and skeleton research centre"

Jérôme Guicheux (50 yo, PhD-DSc 97’) is full professor/senior research director at the French national institute for health and medical research (INSERM). He is director of the research center RMES “regenerative medicine and skeleton” (120 people, INSERM U1229, Nantes, France). He is coordinator of the French INSERM osteoarthritis network. He is a member of the board of directors of OARSI and Regenerate-Biospine. He has authored more than 190 indexed publications (google scholar H-index 60, total citations >9000). His research focuses on the pathophysiology of skeletal tissues and biomaterials/stem cells-based regenerative medicine of cartilage and intervertebral disc. Researcher ID: F-7767-2013


European Molecular Biology Laboratory

Kristina Haase holds degrees in Mechanical Engineering and Physics from the University of Ottawa. She held an NSERC postdoctoral fellowship carried out in Roger Kamm’s group at Massachusetts Institute of Technology. Her work focused on developing macro-scaled fluidic chips for modelling vascular diseases. Kristina joined the European Molecular Biology Laboratory in October 2019 and has a group in the newest EMBL site in Barcelona – dedicated to research in tissue biology and disease. Her group focuses on developing novel vascularized in vitro tissues for disease modelling, drug development and regenerative medicine – particularly for placental, tumoral, and cardiac tissues.


THT Biomaterials GmbH

Dr. Hackethal finished his Master studies in “Tissue Engineering and Regenerative Medicine” at FH Technikum Vienna, Austria and “Medical biology” at Linköping University, Sweden. His doctoral thesis was performed at BOKU Vienna, Austria and the Ludwig-Boltzmann-Institute for Experimental and Clinical Traumatology under supervision of Prof.Dr. Heinz Redl (Hackethal et al., 2017. TEC 23(5); Hackethal et al., 2018. Advances in Experimental Medicine and Biology, DOI 10.1007/97898113094721, PCT/EP2019/058534). After finishing pHD, in June 2020, Dr. Hackethal founded THT Biomaterials GmbH, with the aim, to realize an affordable, sustainable and personalized Medicine by use of non-cellular human proteins from placenta.

University College London

Nick Hamilton is an ENT surgeon and lecturer at University College London’s Head and Neck Academic Centre. Nick’s research is focused on the use of cell therapies to restore voice, swallow and airway function within the throat. He has pioneered implanting epithelial grafts to regenerate the upper airway mucosal lining and investigated its use in overcoming the limitations of bioengineered airway scaffolds. He is currently developing a cell sheet that can engraft within the throat to treat post-radiotherapy fibrosis. His work is supported by the National Institute for Health & Research, Medical Research Council and the Academy of Medical Sciences.


Uppsala University

His research interests are in the design, synthesis and preparation of polymers and specific materials for tissue scaffolds and as delivery vehicles. Special focus is on cell-free hydrogels for bone and cornea with the design of mechanically tough fully biodegradable hydrogels and translation of new drug delivery strategies to the clinic and products. He received his PhD from the Royal Institute of Technology in Stockholm which was followed by seven years in industry before he joined the Swiss Federal Institute of Technology ifor eight years. He has published more than 400 scientific publication and patents and has started seven companies.

Eindhoven University of Technology

Sandra Hofmann is Associate Professor in Bioengineering Bone at the Department of Biomedical Engineering and the Institute for Complex Molecular Systems at the Eindhoven University of Technology. Her research aims to develop human cell-based, functional in vitro bone organoids to study cell interactions with each other and their environment during health and disease. Her current work is supported by grants from the European Research Council, the Dutch Research Council and the Dutch Ministry of Education, Culture and Science.


University of Cambridge

Dr Yan Yan Shery Huang leads the Biointerface group at the Department of Engineering, University of Cambridge. She obtained MEng degree in Materials Science and Engineering from Imperial College London; then completed her PhD thesis in the field of Experimental Soft Matter under theoretical physicist, Prof Eugene Terentjev at the University of Cambridge. After graduating from her PhD in 2011, she was awarded an Oppenheimer Fellowship and a Homerton College Junior Research Fellowship. She is a recipient of an ERC-starting grant award, and is a fellow of the Institute of Materials, Minerals and Mining (FIMMM).

The Ohio State University

Amanda Hummon earned her A.B. in chemistry at Cornell University and her Ph.D. in analytical chemistry at the University of Illinois, in the laboratory of Prof. Jonathan V. Sweedler. She completed her postdoctoral work at the National Cancer Institute. She is currently an associate professor in the Department of Chemistry and Biochemistry and the Comprehensive Cancer Center at The Ohio State University. Her laboratory develops mass spectrometric methods to explore cancer tissues, cell cultures, and organoids. She has been recognized with an NSF CAREER award, the Presidential Early Career Award for Scientists and Engineers (PECASE), and a Fulbright Scholar Award.

Dongguk University

Dr. Im is currently Professor in Department of Orthopaedics and Director of Integrative Research Institute for Regenerative Biomedical Engineering, Dongguk University, Goyang, Korea. 
Dr. Im has been working on the field of osteoarthritis, stem cell and cartilage regeneration of since 1996. He has published 150 peer-reviewed scientific papers in international journals and holds 18 national and international patents. Dr. Im has been performing multidisciplinary research in cooperation with scientist and engineers of various fields to translate the research product into clinical application. He has participated in global academic activity in the field of musculoskeletal research during last two decades.


Pohang University of Science and Technology

Dr. Jinah Jang received her PhD at Pohang University of Science and Technology (POSTECH) in Korea, and trained as postdoctoral fellow in POSTECH and Institute for Stem Cell and Regenerative Medicine at University of Washington. She has joined the POSTECH in 2017 as an assistant professor in the Creative IT Engineering, Mechanical Engineering, and School of Interdisciplinary Bioscience and Bioengineering. She has published 57 peer-reviewed articles in journals including Science Advances, Nature Communications, and Biomaterials (H-index: 24). Her research interest lies in engineering the functional human tissues using high-performance stem cells and printable biomaterials via the 3D bioprinting technology.


Imperial College London

Julian Jones leads a research group on bioactive glasses and hybrids, particularly 3D scaffolds and therapeutic nanoparticles. He has >130 articles and 4 patent applications and has co-edited three biomaterials text books. He was elevated to Fellow of the Society for Glass Technology in 2018, Fellow of the American Ceramics Society in 2015; was awarded an ISCM (International Society for Ceramics in Medicine) Excellence Award in 2016; the 2014 Vittorio Gottardi Award from the International Commission on Glass (ICG). He is Chair-elect of the Bioceramics Division of the American Ceramics Society and Editor of the RSC Biomaterials Science Book Series.


Tufts University

David Kaplan is the Stern Family Endowed Professor of Engineering at Tufts University, Distinguished University Professor, and Professor and Chair of the Department of Biomedical Engineering. His research focus is on biopolymer engineering to understand structure-function relationships and on tissue engineering and regenerative medicine. His lab has published over 900 peer reviewed papers, he is the editor-in-chief of ACS Biomaterials Science and Engineering, and he serves on many editorial boards and programs for journals and universities, and has received a number of awards for teaching and research.




Graduate School of Pharmaceutical Sciences, Nagoya University

  • 2004 - 2004 Post-Doctoral Fellow, Dept. of Biotechnology, School of Engineering, Nagoya Univ.
  • 2004 - 2006 Assistant Prof., Dept. of Cell Therapy, Nagoya University School of Medicine
  • 2006 - 2012 Assistant Prof., Dept. of Biotechnology, Graduated School of Engineering, Nagoya Univ.
  • 2012 - Principal investigator/Associated Prof., Division of Bioscience, Department of Basic Medicinal Sciences, Graduate School of Pharmaceutical Sciences, Nagoya University
  • 2014 - ISO-TC276 Japan committee member (WG3, WG4)
  • 2018 - ISO-TC276 expert member (WG4) Project Leader of Cell Processing Management Standard
  • 2018 - Member of Institute of Nano-Life-Systems, Institute for Innovation for Future Society, Nagoya University

Terasaki Research Institute

Ali Khademhosseini is the CEO and Founding Director at the Terasaki Institute for Biomedical Innovation. He is also a researcher at Amazon Web Services Inc. Previously, he was a Professor of Bioengineering, Chemical Engineering and Radiology at the University of California-Los Angeles (UCLA). Previously, he was a Professor at Harvard Medical School and faculty at the Harvard-MIT’s Division of Health Sciences and Technology, Brigham and Women’s Hospital and an associate faculty at the Wyss Institute for Biologically Inspired Engineering. He received his Ph.D. in bioengineering from MIT, and MASc and BASc degrees from University of Toronto both in chemical engineering.

Department of Biotechnology, Osaka University

Masa (Masahiro KINO-OKA) is one of leaders in the field of cell manufacturing, who contributes to the standardization of the cell processing facility and manufacturing. His current research interests are “Bioprocess engineering” to establish the cell and tissue manufacturing system.
Toward the current professional status, Masa earned the Ph.D. (chemical engineering) in 1996, and he spent one year as a visiting staff in the Department of Chemical Engineering, National Institute of Switzerland (ETH) in Zurich. After returning, he promoted twice in his five-year tenure, and he earned a current position of Professor in Biotechnology, Osaka University since 2009.


Mayo Clinic

James L. Kirkland, M.D., Ph.D., is Director of the Robert and Arlene Kogod Center on Aging at Mayo Clinic and Noaber Foundation Professor of Aging Research. Dr. Kirkland’s research is on cellular senescence, age-related adipose tissue and metabolic dysfunction, and development of agents and strategies for targeting fundamental aging mechanisms to treat age-related chronic diseases and disabilities. He published the first article about agents that clear senescent cells – senolytic drugs. He is a scientific advisory board member for multiple companies, academic organizations, and governments.


3Bs Research Group, University of Minho, AvePark, GMR, Portugal

Subhas C. Kundu is European Research Area Chair and Professor at I3Bs - Biomaterials, Biodegradables and Biomimetics, University of Minho, Portugal under European Commission. He obtained PhD in Genetics, post-docs at Molecular Biology Institute, Moscow, York University, Canada, Lubeck Medical University, Germany, and Brunel University, UK; was Founder Head and Professor, Department of Biotechnology, Indian Institute of Technology Kharagpur, Invited Professor, Dankook University, Korea, Professor at Manipur University, used to teach Genetics, Cell & Molecular Biology, Recombinant DNA Technology; has H-index 56; citations15,376 and current research interest is on 3D cancer modeling using natural biomaterial matrices for drug screening.

Eindhoven University of Technology

Dr. Nicholas Kurniawan is an Assistant Professor at the Department of Biomedical Engineering in Eindhoven University of Technology, the Netherlands. His research focuses on understanding how the physical and mechanical interactions between cells and cellular environments shape physiological tissue function and drive pathologies. His interdisciplinary team combines approaches from biophysics, mechanobiology, microfabrication, and cell biology with an outlook of exploiting cell–materials interactions for regenerative medicine applications. His work is supported by grants from the European Research Council, the Dutch Research Council, the Dutch Ministry of Economic Affairs and Climate Policy, and the Dutch Ministry of Education, Culture and Science.


Sheffield Hallam University

Christine is Professor of Cell biology and Tissue Regeneration and leads the Tissue Engineering and Biomechanics Research Group at Sheffield Hallam University, UK. Her research focuses on understanding the pathogenesis of musculoskeletal disorders and utilising this knowledge to develop novel therapeutic approaches. Her research to date has led to >20 million in research funding, 2 patent families, ~80 peer reviewed publications with a current H index of 34 and ~6000 citations on her work to date. She has supervised 14 doctoral students to completion and currently supervises 7 doctoral students.

Peking University People's Hospital

Jianhao Lin is a leader in joint surgery in China, with research interests in the development of cartilage regeneration and joint reconstruction strategies. He is Head of the Arthritis Clinic and Research Center at Peking University, Chair of the Beijing Joint Health Foundation, and Chair of the Asian Alliances Committee of Osteoarthritis Research Society International (OARSI). His basic science research focuses on the physical microenvironment of MSCs and their applications in tissue engineering and regenerative medicine, particularly for musculoskeletal tissues. He serves on many journal editorial boards including HSS and OAC Open.

Centre for Translational Bone, Joint and Soft Tissue Research, Technische Universitaet Dresden

Anja Lode is group leader ‚Bioprinting‘ at the Centre for Translational Bone, Joint and Soft Tissue Research, Faculty of Medicine of Technische Universitaet Dresden. She studied Biology at the University of Potsdam and earned her PhD degree in Genetics at the Technische Universitaet Dresden. In 2002, she started to work in the field of tissue engineering, stem cell differentiation and cell-biomaterial interactions. Her current research focuses on the development and characterization of bone replacement materials as well as novel materials and strategies for extrusion-based 3D (bio)printing for applications in regenerative medicine and biotechnology. 



University of Pennsylvania

Claudia Loebel is currently a postdoctoral fellow in the laboratory of Professor Jason Burdick at the University of Pennsylvania (United States). She obtained her MD (2011) at the Martin-Luther University Halle-Wittenberg (Germany) and completed her PhD (2016) at ETH Zurich and the AO Research Institute (Switzerland). She has been awarded the Silver Medal of ETH and postdoctoral fellowships by the Swiss National Science Foundation and IBSA Foundation. Her research interests are on the development of biomaterial platforms to address specific problems related to tissue repair and therapeutic treatment.

KU Leuven-RegmedXB

Professor Emeritus KU Leuven
Medical/Scientific Director RegmedXB





Stanford University

Sarah Heilshorn is Professor in the Materials Science & Engineering Department at Stanford University. Her laboratory integrates concepts from materials science and protein engineering to design bioinspired materials for regenerative medicine, organoid culture, and bioprinting. She is a fervent supporter of diversifying the research community. She is a Fellow of the American Institute for Medical and Biological Engineering and the Royal Society of Chemistry. She serves as Associate Editor of the journal Science Advances, Special Content Editor of Acta Biomaterialia, and on the Board of Directors for the Materials Research Society and the International Society for Biofabrication.




Universität des Saarlandes, Lehrstuhl für Experimentelle Orthopädie und Arthroseforschung

- Clinician-scientist
- MD in 1996 from Humboldt University, Berlin
- Resident, Department of Trauma Surgery, Charité Medical School, Berlin and Department of Orthopaedic Surgery, Saarland University
- Board-certified in Orthopaedic Surgery in 2004
- Postdoctoral fellow: Massachusetts General Hospital, Harvard Medical School and Massachusetts Institute of Technology
- Since 2009 Full Professor and Director of the Center of Experimental Orthopaedics at Saarland University with joint appointment in Department of Orthopaedic Surgery
- Research focus: Fundamental and translational aspects of osteoarthritis and cartilage repair. Clinical practice: Regenerative surgical treatments for cartilage defects of the knee and osteoarthritis


Georgia Institute of Technology

Sakis Mantalaris is Professor in the Department of Biomedical Engineering at Georgia Tech & Emory. Prior, he was Professor at Imperial College London. His expertise is in modelling of biological systems and bioprocesses with a focus on stem cell bioprocessing. He has published over 170 manuscripts, co-edited one book, and holds several patents. He has been awarded the Junior Moulton Award by the IChemE (2004), was elected Fellow of the American Institute for Medical & Biological Engineering (2012), awarded a European Research Council (ERC) Advanced Award (2013), and the Donald Medal by IChemE (2015) for his contributions to biochemical engineering


University of Aveiro

João F. Mano is a Full Professor at the Chemistry Department of University of Aveiro, Portugal. He is the director of the COMPASS Research Group, from the research unit CICECO – Aveiro Institute of Materials, focusing on the use of advanced biomaterials and cells towards the progress of transdisciplinary concepts to be employed in regenerative and personalised medicine. He is the Editor-in-Chief of Materials Today Bio (Elsevier). He has been coordinating several national and European research projects, including Advanced and Proof-of-Concept Grants from the European Research Council.



Heart Institute Cedars-Sinai Medical Center

Eduardo Marbán, MD, PhD, is an international leader in cardiology and a pioneering heart researcher. His 30-plus years of experience in patient care and research have led to key discoveries in gene- and cell-based therapies for heart disease. Those discoveries have formed the basis for multiple startup companies. In 2007, Marbán became founding director of the Cedars-Sinai Heart Institute, which was renamed the Smidt Heart Institute in 2018. The Smidt Heart Institute has been ranked by US News and World Report as the top heart program in the western USA since 2013.

TissUse GmbH, Technische Universität Berlin

Since 2010 Uwe Marx is the CEO and founder of TissUse, a “Human-on-a-chip” spin-off company of the Technische Universität Berlin. He pioneered various programs in the “Multi-organ-chip” field. Between 2000 and 2010 Dr. Marx joined German the biotech ProBioGen, whichnhe founded in 1994, as the Chief Scientific Officer. Prior to that, he spent his scientific career at the University of Leipzig (1995-2000) and at the Charité Berlin (before 1995). He received his doctorate degree in immunology from the Humboldt University, Charité in Berlin. Dr. Marx has published more than 60 peer-reviewed papers and is inventor in 26 patent families.

Utrecht Institute for Pharmaceutical Sciences, div. Pharmacology

Roos Masereeuw (UU) received her PhD from Radboud University in Nijmegen in January 1997 and joined the Dept. of Pharmacology and Toxicology at Radboudumc as assistant professor. In July 2002, she was appointed as associate professor after obtaining an NWO-ASPASIA award. In 2009, she received the Dutch Pharmacological Society (NVF) Schering-Plough Pharmacology Award, in 2010 the Prix Galien Research Award and in 2015 she was elected Fellow of the American Association of Pharmaceutical Scientists. Since July 2015 she is full professor of Experimental Pharmacology and since November 2018 scientific director of Utrecht Institute for Pharmaceutical Sciences in The Netherlands.

University of Nottingham

Alvaro Mata is Professor in Biomedical Engineering and Biomaterials in the School of Pharmacy and the Department of Chemical and Environmental Engineering at the University of Nottingham. He holds a Doctor of Engineering Degree working with Prof. Shuvo Roy at the Cleveland Clinic prior to postdoctoral training working with Prof. Samuel Stupp at Northwestern University. His group aims to harness biomolecules and supramolecular events found in nature to develop innovative materials and biofabrication processes. His work has led to seven patents or patent applications and publications in journals including Nature Materials, Nature Chemistry, Nature Communications, and Advanced Functional Materials.

Aarhus University

Rikke Meyer is PhD in microbiology and Associate professor at the Interdisciplinary Nanoscience Center at Aarhus University, Denmark. She is heading a research group that studies now bacteria form biofilms, and how to prevent or treat biofilms by exploiting recent advancements in nanotechnology. Her research addresses the fundamental questions of how bacteria interact with material surfaces, and she brings this knowledge into application in collaboration with industry partners from the health, food, and water technology sectors.


Universidad de Las Palmas de Gran Canaria

Dr. Mario Monzón is a full professor in the Mechanical Engineering Department of Las Palmas de Gran Canaria University . He is the coordinator of the research group of Integrated and Advanced Manufacturing, which main research fields are Polymer processing, additive manufacturing (AM), rapid tooling, natural fibres and applications in composite materials and technical textiles, circular economy, biomaterials for additive manufacturing and biofabrication. He is a member of the committee ISO TC261 and CEN TC438 for standardization of additive manufacturing technologies. Also, He is the convenor of the Joint working group JWG11 “Additive Manufacturing for Plastics”.

Harvard University

David Mooney is the Pinkas Family Professor of Bioengineering in the Harvard School of Engineering and Applied Sciences, and a Core Faculty Member of the Wyss Institute. His laboratory designs biomaterials to promote regeneration and immunotherapy. He is a member of the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Inventors. His inventions have been licensed by over 15 companies, leading to commercialized products. He has founded companies, and is active on industrial scientific advisory boards.



Regenerative Medicine Technologies Lab, Ente Ospedaliero Cantonale, Lugano, CH

Matteo Moretti is Director of the Regenerative Medicine Technologies Laboratory at EOC, Lugano, Switzerland and of the Cellular and Tissue Engineering Laboratory at the IRCCS Galeazzi Orthopedic Institute, Milan, Italy. He has been post-doc fellow in Langer Lab, Massachusetts Institute of Technology. His research focuses on the generation of 3D human biological replicates as patho-physiological models of musculoskeletal tissues, through advanced multiscale technologies. He has been member of TERMIS since its foundation, co-founder of SYIS section and TERMIS-EU Treasurer and Council Executive Committee member (2015-19). He co-founded 2 biotech start-ups and has authored more than 80 peer-reviewed journal articles.


Ecole Polytechnique Federale de Lausanne

Christophe Moser is Associate professor of optics and Section Director in the MicroEngineering Institute at EPFL. His current research interests are micro-endoscopic imaging through multimode fibers, retinal imaging and additive manufacturing via volumetric 3D printing with light. His group developed a single photon volumetric 3D bioprinter technology capable of printing high resolution centimeter scale live cell laden complex constructs in matters of seconds by tomographic back-projection. He holds a PhD from Caltech and was the CEO of Ondax for 10 years prior to joining EPFL. He is the author and co-author of 75 peer reviewed publications and over 50 patents.


UC San Diego

Dr. Muotri earned a Ph.D. in Genetics in 2001 from the University of Sao Paulo, Brazil. He moved to the Salk Institute as Pew Latin America Fellow in 2002 for postdoctoral training in the fields of neuroscience and stem cell biology. He has been a Professor at the School of Medicine, University of California in San Diego since 2008. His research focuses on modeling neurological diseases, neurodevelopment and, brain evolution using brain organoids. He has received several awards, including the prestigious NIH Director’s New Innovator Award, NARSAD, Rock Star of Innovation, NIH EUREKA among others.


Saga university

Professor Koichi Nakayama is a regenerative medicine and tissue engineering researcher at Saga University. He has established a method to fabricate transplantable, 3-D scaffold-free tissue. Koichi’s long-term goal is to manufacture living organs for transplantation based on a combination of robotic technology and biotechnology.



University of Minho

Nuno M. Neves is an Associate Professor with Habilitation at the 3B’s Research Group of the University of Minho, Portugal. He has been involved in biomaterials research since 2002 and is currently Vice-President of the I3Bs Research Institute. His main area of research is focused on tissue engineering and regenerative medicine strategies using stem cells and biodegradable biomaterials for advanced drug delivery systems, scaffolds and medical devices. He is the author of 199 publications with an h-factor of 43 and is the co-inventor of 7 patents.


University of Milano-Bicocca

Francesco Nicotra professor of Organic Chemistry at University of Milano-Bicocca, Past-President of the IUPAC Division of Organic and Biomolecular Chemistry, Italian representative in the International Carbohydrate Organization. Scientific interests in Bio-organic chemistry, with particular attention to glycoscience. Recipient of the Award for innovation in research of the Italian Chemical Society; the Medal Berti for Research in Carbohydrate Chemistry and the Medal Quilico of the Division of Organic Chemistry of the Italian Chemical Society. Plenary and Keynote speaker in > 50 International Conferences. >200 publications, 18 chapters of books, 12 patents, H index 39 (Google Scholar), 34 (Scopus)


Medical University of Vienna, Department of Orthopedics and Trauma-Surgery, Division of Trauma Surgery

Sylvia Nürnberger, PhD is a principle investigator at the Medical University of Vienna, Department of Orthopedics and Trauma-Surgery and the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology. She has studied Biology at the University of Vienna and is since 2014 the scientific head of the “Cartilage Regeneration” group of the “Austrian Cluster of Tissue Regeneration”. A strong focus of her work is the development and characterization of biomaterials (scaffolds and glues) and alternative cell therapies. Together with her group and collaboration partners, she recently developed and patented different strategies for repopulation of decellularized cartilage.


University of Minnesota, Department of Biomedical Engineering

Brenda Ogle is Professor and Head of Biomedical Engineering, Professor of Pediatrics, and Director of the Stem Cell Institute at the University of Minnesota. Her research team investigates the impact of extracellular matrix proteins on stem cell behavior especially in the context of the cardiovascular system. Her work received funding from the NIH, NSF, DOD, and AHA. She has partnered with Becton Dickinson, iCyt and Medtronic. Professor Ogle is an elected fellow of AIMBE, was a member of the Board of Directors of BMES, and is a recipient of the Mullen-Spector-Truax Women’s Leadership Award.


TU Wien

Prof. Aleksandr Ovsianikov is a head of the research group 3D Printing and Biofabrication at the TU Wien (Vienna, Austria). He is a member of the Austrian Cluster for Tissue Regeneration ( and was recently elected to the board of directors of the international society of biofabrication ( A particular focus his current research is the development of multiphoton lithography technologies for high-definition bioprinting of 3D cell culture matrices and realization of novel tissue engineering scaffolds. He was awarded prestigious European Research Council (ERC) Starting Grant in 2012 and a Consolidator Grant in 2017 for projects aimed at these topics.


University of Wisconsin - Madison

Prof. Sean Palecek is the Milton J. and Maude Shoemaker Professor of Chemical and Biological Engineering at the University of Wisconsin – Madison, the Director for Research for the National Center for Cell Manufacturing Technologies, and Director for Research Innovation of the Forward BIO Institute. Prof. Palecek’s research group develops processes for biomanufacturing of cells and tissues from human pluripotent stem cells, with a current focus on cardiovascular and neurovascular lineages. They strive to engineer robust, scalable platforms to produce high quality cells and tissues for in vitro diagnostics as well as regenerative medicine applications.


Hallym University

I graduated the Hallym Univsersity Medical School(M.D.) in 1996. He obtained Ph.D. degree from KangWon National University, Korea. I have been working in chief(associate professor) of the department of Otorhinolaryngology Head & Neck Surgery in Chunchon Sacred Heart Hospital of Hallym Medical Center from 2004. My major study’s field of medical part is the facial surgery and reconstruction such as rhinoplasty, facial trauma, skin cancer etc. I studied the biomaterials for facial reconstruction such as Gore-Tex, Silicone, metal plate, absorbable fixation plate etc. And I was developing biomaterials using silk fibroin from 2008


University of Zaragoza

María Angeles Pérez is Full Professor of Structural Mechanics at the University of Zaragoza (Spain). Her research focusses on the multiscale and multi-physics modelling of biological processes (bone remodeling, tissue engineering and cellular mechanobiology). María Angeles is the PI of the research group Multiscale in Mechanical and Biological Engineering (M2BE), where they combine computational models (in silico) with experimental data (in vitro) obtained from their cellular mechanobiology lab. She has been President of the European Society of Biomechanics (2018-2020) and now is Associate Director of the Aragón Institute of Engineering Research (I3A).

University College London

Dr Qasim Rafiq is an Associate Professor at University College London in Cell and Gene Therapy Bioprocessing. He is a multidisciplinary engineer and currently leads a research portfolio of >£3.5m and heads up the ATMP Bioprocess Engineering group which includes 4 PDRAs and 12 PhD students. He is the Programme Director of a new MSc programme in the Manufacture and Commercialisation of Stem Cell and Gene Therapies. He is both a Chartered Engineer (CEng) and Chartered Scientist (CSci) and sits on multiple scientific and engineering committees including the BIA’s Cell and Gene Therapy Advisory Committee and BSI’s Biotechnology Standards Group.


Zurich University of Applied Sciences

Michael Raghunath is a physician scientist heading the Center for Cell Biology and Tissue Engineering at the Institute for Chemistry and Biotechnology at the Zurich University of Applied Sciences. He is council member of TERMIS EU. His basic and translational research experience spans more than 28 years during which he became an internationally distinguished scientist in the field of matrix biology (pathobiochemistry of collagens and elastic microfibrils) and skin biology (wound repair, cornification disorders). Developing macromolecular crowding as principle in cell biology, he has created a novel field in Tissue Engineering to build cell-specific and lineage-directing microenvironments.


Virginia Tech

Dr. Padma Rajagopalan is the Robert E. Hord Jr. Professor of Chemical Engineering at Virginia Tech. She serves as the program director for the Interdisciplinary Graduate Education Program on Computational Tissue Engineering. Dr. Rajagopalan’s research focuses on the assembly and function of liver organoids, integrated intestinal-liver platforms and cellular migration in 3D. An increasing focus of her research is to utilize computationally driven tissue engineering to predict tissue function. Dr. Rajagopalan was elected Fellow of the American Institute of Medical and Biological Engineering in 2017.


3B´s Research Group - University of Minho

Professor Rui L. Reis is the Director of the 3B’s Research Group - member of the I3Bs – Institute for Biomaterials, Biodegradables and Biomimetics, and Director of the ICVS/3B’s Associate Laboratory, both of UMinho. He is also the CEO of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, the Past-President of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) and the Editor-in-chief of Journal of Tissue Engineering and Regenerative Medicine. He is a recognised World expert in the TERM and biomaterials fields, that has edited several books and has more 1300 publications listed in ISI WoK.


Bioforge Lab. University of Valladolid

Full Professor of condensed Matter Physics and CEO of Technical Proteins NBT S.L.. Expert in biomaterials and biomedical engineering. My research interest lies on the recombinant production of bioinspired polypeptides and the use of those designed macromolecules in a broad range of applications from more basic science around self-organization and order-disorder interplay in natural proteins to the use of such materials in regenerative medicine and nanomedicine.


Department of Materials Science and Engineering, University of Sheffiel

Professor Ipsita Roy is an expert in Microbial Biotechnology, Biomaterials and Tissue Engineering. She is currently a Professor at the Department of Materials Science and Engineering, Faculty of Engineering, University of Sheffield. She was awarded the Inlaks Scholarship to study for her Ph.D. at the University of Cambridge. Her postdoctoral work was at the University of Minnesota, USA. She has published over 100 papers in high ‘Impact Factor’ journals such as Biomaterials, Biomacromolecules, Journal of Royal Society Interface. Her group is currently focussed on the production of natural polymers, including Polyhydroxyalkanoates (PHAs), Bacterial cellulose, Alginate, their characterisation and biomedical applications.


University of Glasgow

Manuel is Professor of Biomedical Engineering and co-director of the Centre for the Cellular Microenvironment at the University of Glasgow. He did a PhD in Valencia and postdoctoral research in Prague and Leuven. He was Full Professor at Universitat Politecnica de Valencia and Visiting Professor in Georgia Tech. His group has pioneered polymers that trigger the self-assembly of proteins to promote high efficiency presentation of growth factors. His research lies at the cell/material interface, with interests in in vitro models for drug screening and disease modelling, along with materials for cancer research, stem cell engineering and regenerative medicine.


Living Systems Institute, University of Exete

After secretion, developmental signals such as the Wnt morphogens must travel relatively long distances to form a concentration gradient that the responding tissue uses to acquire positional information. The role of Wnt transport and endocytic trafficking in this process is the subject of intense debate. My team has shown that Wnt is transported on long, actin-based filopodia - known as cytonemes to contact responding cells and activate signalling in human gastric tumour tissue and zebrafish embryogenesis. We are in the process of deciphering the molecular mechanism controlling cytoneme formation and the consequences on cell signalling and tissue development and homeostasis.

Queen Mary University of London

Hazel Screen is Professor of Biomedical Engineering at Queen Mary University of London. Her research centres on healthy and pathological tissue structure-function behaviour and its interplay with mechanobiology. She has a particular interest in tendon and ligament, and leads a highly multidisciplinary group which spans human and animal in vivo and in vitro studies of tendon function and injury. She also leads the UK Organ-on-a-Chip Technologies Network and is interested in developing novel in vitro models of musculoskeletal tissues which integrate learning from structure-function studies to recapitulate appropriate physiochemical cues.


AO Research Institute Davos

Tiziano Serra is a research scientist at Sound Guided Tissue Regeneration group in AO Research Institute Davos (ARI). He is also CSO and co-founder of mimiX Biotherapeutics ( Tiziano has been awarded the Young Investigator Award from the International Society of Biofabrication and the Julia Polak European Doctoral Award from the European Society of Biomaterials. His research activities are focused on the development of advanced biofabrication technologies for the generation of complex multicellular systems for drug screening and clinical translation.


1- Herston Biofabrication Institute, Metro North Hospital and Health Service. 2- UQ Diamantina Institute, The University of Queensland

Dr. Abbas Shafiee is a regenerative medicine scientist interested in cell-based and tissue engineering strategies to treat human diseases. He completed his PhD in Professor Khosrotehrani lab on stem cell biology. Then, he joined Professor Hutmacher’s team and conducted multiple projects on the application of tissue engineering concepts for cancer studies and bone regeneration. Dr. Shafiee joined Herston Biofabrication Institute in 2020 and started a research program to develop, implement, and evaluate applications of 3D printing, scanning, cell therapies, and biofabrication technologies in skin wound settings. He has been awarded multiple research grants, awards, and published over 55 research articles.


Nationwide Children's Hospital

1983 M.D. Hiroshima University, School of Medicine 1994-1997 Research fellows in Children's Hospital, Boston, Harvard Medical School 1998- 2001 Assistant Professor, Department of Pediatric Cardiovascular Surgery, Tokyo Women's Medical University 2001-2004 Associate Professor, The institute of Advanced Biomedical Engineering & Science, Tokyo Women’s Medical University 2004-2006 Professor, Division of Cardiovascular Tissue Engineering, Tokyo Women’s Medical University 2007-present Visiting Professor, Department of Cardiovascular Surgery, Tokyo Women’s Medical University 2007-2012 Director of Pediatric Cardiovascular Surgery, Yale New Haven Hospital 2012-present Professor of Surgery, Ohio Stage University Director of Cardiovascular Tissue Engineering Program, Nationwide Children’s Hospital

Hanyang University

Heungsoo Shin is currently a professor in the Department of Bioengineering, Hanyang University, South Korea. He received his Ph.D. in the Department of Bioengineering from Rice University, USA (2004), and was a postdoctoral researcher at the Department of Mechanical Engineering, Georgia Institute of Technology, USA. The main research thrusts in his laboratory include 1) development of biomimetic materials for cell and growth factor delivery in tissue engineering, 2) 3D culture and stem cell engineering, and 3) characterization of cell‐extracellular matrix interactions. His works particularly have led to innovative approaches in the regeneration of impaired musculoskeletal tissue.


University of Delaware - Biomedical Engineering    

Dr. Slater received a BS in Mechanical Engineering from the University of North Carolina at Charlotte, graduating Magna Cum Laude, where he received the Danielson Endowment and the James S. Jones Memorial Scholarships. He earned a PhD in Biomedical Engineering with a Portfolio Degree in Nanoscience and Nanotechnology from the University of Texas where he was a NSF Graduate Research, Biomedical Engineering Tom Collins, and a Thrust Fellow. He was a NIH Nanobiology Postdoctoral Fellow and a HHMI Postdoctoral Fellow in the Bioengineering Department at Rice University. He is an Associate Professor of Biomedical Engineering at the University of Delaware.


Eindhoven University of Technology

Anthal Smits is Assistant Professor at the Department of Biomedical Engineering and the Insitute for Complex Molecular Systems at Eindhoven University of Technology. He set up and leads the ImmunoRegeneration Group, which specializes in immunomodulation to induce in situ tissue regeneration. The main research goal is to gain a mechanistic understanding of the interactions between human immune cell behavior, biomaterial design, and biomechanical loads, in conditions of health and disease. Smits’ main clinical target applications are cardiovascular replacements (e.g. heart valves and blood vessels), yet, the research is curiosity-driven, and applicable to a wide variety of clinical applications.


University of Twente

“Prof. Dr. Dimitrios Stamatialis obtained his PhD at NRC “Demokritos” (Athens – Greece) in 1995 in the field of physical chemistry and membranes. He is full professor of (bio)artificial organs at the University of Twente in the Netherlands. 
Prof. Stamatialis has been involved in numerous projects leading to products and applications, some licensed to companies. He is author of more than 145 scientific papers and inventor of 9 patents. He has various international activities, including: Chairman of the working group on bioartificial organs of the European Society of artificial organs (ESAO) and editor of the “international journal of artificial organs”.



AO Research Institute Davos

Prof. Martin Stoddart has a Principal Scientist at the AO Research Institute Davos Since 2009. In 2020 he became head of the Regenerative Orthopaedics Program. He is Professor at Albert-Ludwigs University, Freiburg, Germany and an Honorary Professor at Keele University, UK. In 2016 he became Fellow of the Royal Society of Biology and ICRS Fellow Member. He is Chair of LearnORS and scientific editor for eCM Journal. He is a member of the TERMIS EU Meeting and Sponsorship Committee and the International Consortium for Regenerative Rehabilitation Leadership Council. He is the author of over 120 scientific papers and book chapters.


Institute for Frontier Life and Medical Sciences, Kyoto University

Dr. Yasuhiko Tabata is the Professor of Institute for Frontier Life and Medical Sciences, Kyoto University and guest professors of 17 different universities. He received his BD in Polymer Chemistry (1981), Ph.D. (1988) in Technology, D.Med.Sc. (2002), and D.Pharm. (2003) all at Kyoto University. He was a Visiting Scientist at the MIT (Professor Robert Langer) (1991-92). He has published 1,630 scientific papers including 145 book chapters and review articles, and has 130 patents. He received the Scientific Award from the Japanese Society for Biomaterials (2002), the Japan Society of Drug Delivery System (2011), TERMIS-AP (2018), and 5 other scientific awards.


McGill University

Maryam Tabrizian is Canada Research Chair holder in Regenerative Medicine and Nanomedicine, cross-appointed between Faculty of Medicine-Biomedical Engineering Department and the Faculty of Dentistry at McGill University. She was the founding director of the Centre for Biorecognition and Biosensors and has received many prestigious awards (Career award, Guggenheim foundation, Biomaterials Science & Engineering, RSC-Academy of Science, ADEA Leadership Institute, Canadian Academy of Health Sciences,..). She is expertise in the design of advanced biomaterials and biointerfaces for their applications in nanomedicine, regenerative medicine and Lab-on-a-chip devices. Professor Tabrizian authored over 235 papers (H-index 61) and is the EIC of Materials (MDPI).

Vision Care Inc.

Masayo Takahashi received her M.D. and Ph.D. from Kyoto University. She moved to the Salk Institute, where she discovered the potential of stem cells as a tool for retinal therapy. She joined RIKEN as a Team Leader. In 2013, her team launched a pilot clinical study of autologous iPS cell-derived RPE cell sheets for exudative aged-related macular degeneration, and performed the first RPE cell sheet graft transplantation in 2014. In 2019, she started a new carrier as a president of start-up company; Vision Care Inc. Her aim is to understand these diseases at a fundamental level and develop retinal therapies.


Tokyo Women's Medical University

Dr. Takahashi is now an associate professor of Institute of Advanced Biomedical Engineering and Science at Tokyo Women’s Medical University (TWMU). He graduated from Department of Engineering, Kyushu University and received Ph.D. in 2006. He then performed postdoctoral research under Prof. David Grainger, Colorado State University and University of Utah, USA. His researches was the development of a hydrogel-based local drug delivery system and cell micropatterning techniques. After that, he moved to TWMU and started researches for tissue engineering and regenerative medicine in 2008. His recent work is focused on muscle tissue engineering for the development of in-vitro tissue model.


Utrecht University

Marianna Tryfonidou is currently doing research on back pain caused by degeneration of the intervertebral disc. Back pain is a major problem in both humans and dogs. She is currently developing two innovative treatments for dogs, which doctors will eventually also be able to use to treat human patients with back pain. These are based on (a) local controlled drug release and (b) an ATMP based on iPS-technology. For this purpose, Tryfonidou has brought together a group of experts from around the world. This iPSpine consortium received 15 million euros from the European Union.


The Chinese University of Hong Kong

Prof. Tuan (Ph.D., Rockefeller University) was a professor at the University of Pennsylvania and Thomas Jefferson University, and Chief of the Cartilage Biology and Orthopedics Branch of the NIH, prior to joining the University of Pittsburgh in 2009 as Founding Director, Center for Cellular and Molecular Engineering, and Professor and Executive Vice Chair, Department of Orthopaedic Surgery, and Professor in the Department of Bioengineering. In 2018, Prof. Tuan moved to Hong Kong and became the Eighth Vice-Chancellor and President of The Chinese University of Hong Kong, and also founded the Institute for Tissue Engineering and Regenerative Medicine at CUHK.

VIB Belgium

Pierre Vanderhaeghen is Professor at the VIB Center for Brain and Disease Research at KU Leuven, and Université Libre de Bruxelles, Belgium. His research is focused the mechanisms of development of the cerebral cortex in direct link with human brain evolution and diseases. His lab uses classical tools such as mouse genetics and embryology, as well as innovative models of corticogenesis from pluripotent stem cells, which were pioneered in his lab.


Banc de Sang i Teixits

I am a Biochemist with extensive experience in the R&D biotech sector, both in private and academic environments. I focused my career on the optimisation of cellular processes towards A) high yield production of diagnostic and therapeutic molecules, and B) the development of methods to produce cells for drug screening and therapy, in compliance with current regulatory and quality standards. Apart from leading MTA production for clinical trials, I focus my research in A) the generation of 3D tissue engineering products, B) the development of animal models for the study of tissue regeneration and identification of biomarkers of tissue remodelling.


University of Pittsburgh

Dr. Yoram Vodovotz is currently a Professor of Surgery, Immunology, Computational and Systems Biology, Bioengineering, Clinical and Translational Science, and Communication Science and Disorders at the University of Pittsburgh School of Medicine. His research focus is the systems biology of inflammation. He is the Director of the Center for Inflammation and Regeneration Modeling (CIRM; at the McGowan Institute for Regenerative Medicine, a co-founder and past President of the Society for Complex Acute Illness (, and a co-founder of Immunetrics, Inc. (, a Pittsburgh-based company that is commercializing this mathematical modeling work. He has published over 300 manuscripts.


Laboratory for Mineralized Tissues, Center for Translational and Clinical Research, University of Zagreb School of Medicine

Slobodan Vukicevic is a full professor and head of Laboratory of Mineralized Tissues, Center for Translational and Clinical Research, University of Zagreb School of Medicine. He is a full member of the Croatian Academy of Sciences and Arts. His scientific interests comprise bone and cartilage morphogenetic proteins and development of drugs for regeneration of bone, kidney and heart muscle. Inventor of more than 30 patents and editor of 4 books on BMPs. Founder of Genera Research, innovation-based biotechnology company developing a novel regenerative therapy for bone defects via coordinating collaborative programs OSTEOGROW (FP7) and OSTEOproSPINE (HORIZON 2020).


RWTH Aachen Medical School

Wolfgang Wagner is Professor of Stem Cell Biology and Cellular Engineering at RWTH Aachen University Medical School (Germany) since 10 years. Furthermore, he is cofounder of the company Cygenia ( that provides service for epigenetic analysis for other scientists since 2014. Prof. Wagner is Editor of the journals PLoS ONE, Scientific Reports and Clinical Epigenetics. His main research interests are 1) epigenetics in hematopoietic differentiation; 2) standardization and characterization of mesenchymal stem cells; 3) interaction of stem cells with biomaterials; and 4) molecular and epigenetic effects of aging, replicative senescence, and malignant transformation.

Cornell university

Dr. Van de Walle received her DVM degree from the Faculty of Veterinary Medicine, Ghent University, Belgium, followed by a PhD from the same institution. She is currently an Associate Professor at the Baker Institute for Animal Health, Cornell University, where she runs her research lab working in the fields of Virology and Stem Cell Biology. In 2016, she was awarded the Zoetis Animal Health Award for Research Excellence, and was named the Harry M. Zweig Assistant Professor in Equine Health in 2017. She has published over 100 papers in peer-reviewed journals and presented at numerous national and international conferences.

University of Oxford

Sarah Waters is Professor of Applied Mathematics at the Mathematical Institute, University of Oxford. Her research is in the application of mathematics to medicine and biology, focusing on quantitative approaches to regenerative medicine, physiological fluid mechanics, and cell and tissue biomechanics. Together with Professor Alicia El Haj, she leads a UK initiative "Quantitative Regenerative Medicine" to embed mathematics and quantitative approaches into the regenerative medicine translation journey, bringing together and supporting leading academics from the mathematical modelling
and regenerative medicine communities to showcase the potential for mathematical modelling in regenerative medicine.


University of Notre Dame

Assistant Professor of Chemical & Biomolecular Engineering, University of Notre Dame, USA


Max Planck Institute for Polymer Research

Prof. Dr. Tanja Weil joined the Max Planck Society in 2017 as one of the directors of the Max Planck Institute for Polymer Research, heading the division “Synthesis of Macromolecules”. She studied chemistry (1993–1998) at the TU Braunschweig (Germany) and the University of Bordeaux I (France) and completed her PhD at the MPI for Polymer Research under the supervision of K. Müllen. Her scientific interests focus on innovative synthesis concepts to achieve functional macromolecules and hybrid materials to solve current challenges in biomedicine and material science.


University of Sydney    

Professor Weiss is the McCaughey Chair in Biochemistry, NHMRC Leadership Fellow, and leads Tissue Engineering & Regenerative Medicine at the CPC University of Sydney. Awards include the Eureka Prize for Innovation in Medical Research, Clunies Ross Knowledge Commercialisation Award, NSW Premier’s Prize for Science & Engineering Leadership in Innovation, Vice Chancellor’s Award for Excellence, Innovator of Influence Award, Applied Research Medal, and the Order of Australia. He is a Fellow of the Royal Society of Chemistry, Australian Academy of Technology and Engineering, Royal Australian Chemical Institute, Royal Society of NSW, AIMBE, Tissue Engineering and Regenerative Medicine, Biomaterials Science and Engineering.

Helmholtz Zentrum Geesthacht, Metallische Biomaterialien

R. Willumeit-Römer studied and obtained a PhD in physics by working on the structure of ribosomes. Habilitation and venia legendi in biochemistry. After working on peptide antibiotics and antimicrobial implant surfaces focus on degradable Mg-based implants. Current position: Director of the Institute for Materials Research, Divison Metallic Biomaterials, Helmholtz-Center Geesthacht and Professor at the Faculty of Engineering, Christian-Albrechts-University, Kiel, Germany.    


Universitätsmedizin Berlin / Regenerative Orthopädie und Unfallchirurgie

Prof. Dr. Tobias Winkler is orthopedic and trauma surgeon at the Center for Muskuloskeletal Surgery (CMSC) of the Charité Berlin. He is coordinator of an international research consortium performing the worldwide only phase III trial of an allogeneic cell therapy for regeneration after skeletal muscle injury. He is head of a research team, which main focus is the translation of advanced therapies for musculoskeletal indications. His research work in the field encompasses cell therapies with adult mesenchymal and blood cells for bone tendon and muscle regeneration and the development of biomaterials for bone regeneration.


University Of Otago

Tim Woodfield is Professor of Orthopaedic Regenerative Medicine, University of Otago Christchurch and Director, Centre for Bioengineering & Nanomedicine. 
His research platform involves 3D Biofabrication and Additive Manufacturing of biomaterials applied to regenerative medicine of cartilage and bone, including: 3D Bioassembly; visible-light hydrogels/bioinks/bioresins; delivery of bioactive factors; 3D-models and high-throughput screening.
He has published over 110 articles (h-index 33) and attracted over NZ$28M in competitive research funding. He is President Elect of the International Society for Biofabrication and sits on the TERMIS Asia Pacific Council. He is Editorial Board Member for Biofabrication, APL Bioengineering, and Frontiers in Bioengineering & Biotechnology.


Queensland University of Technology

Professor Yin Xiao, a dental specialist (BDSc 1986 and MDSc 1991), started his research career in 2000 (Ph.D. from the University of Queensland) and tenured full professor at Queensland University of Technology. He is the Founder and the Director of the Australia-China Centre for Tissue Engineering and Regenerative Medicine (ACCTERM) established in 2013 and the Joint Research Centre of functional biomaterials for tissue and organ replacement. His work has predominantly focused on bone, biomaterials, stem cells, dentistry, osteoarthritis, and tissue engineering. He pioneered the concept of osteoimmunology in bone biomaterial development and introduced the “Materiobiology” in M. Phil training courses.



University of Leeds

Dr Yang (University of Leeds, UK), the head of tissue engineering research, has over 12 years of expertise in clinical orthopaedics and 20 years in bone and cartilage tissue engineering research using stem cell therapy, biomimetic biomaterials and in vitro, in vivo models. He filed 9 patents and published over 100 book/articles/papers. He has given 40 keynote/invited talks. He developed and provide leadership for six international consortia in regenerative medicine. XY has been the Honorary Treasurer and Trustee of the British Orthopaedic Research Society, a member of the scientific committees for many prestigious conferences, grant review panels and editorial boards.

Wake Forest Institute for Regenerative Medicine

Dr. Yoo is a Professor and Associate Director of the Wake Forest Institute for Regenerative Medicine (WFIRM). Dr. Yoo's research efforts have been directed toward the clinical translation of tissue engineering technologies and cell-based therapies. Dr. Yoo has been involved in transferring several cell-based technologies from the bench-top to the bedside. Dr. Yoo has also been a lead scientist in the bioprinting program at WFIRM and has been instrumental in developing skin bioprinting and integrated tissue and organ printing (ITOP) systems for preclinical and clinical applications.

Shenzhen University

Yang Zhang obtained his Ph.D. degree and postdoctoral experience from Radboud University Medical Center, the Netherlands. After that, he joined Shenzhen University as an associate professor. His current research focuses on unraveling roles of the immune microenvironment in tissue regeneration, where he has published more than 20 journal articles. He served as a 29th ESB Academic Committee member and as a peer reviewer for Biomaterials Science, Tissue Engineering, Journal of Biomedical Materials Research, etc. He was also a visiting researcher at Johannes Gutenberg University Mainz (Germany) and Capital Medical University (China).

Harvard Medical School

Dr. Zhang's research interests include 3D bioprinting, organ-on-a-chip, regenerative engineering, and bioanalysis. His scientific contributions have been recognized by >40 awards. He is an author of >190 peer-reviewed publications (H-index: 53) and has delivered >110 invited lectures globally. He is serving as Co-Editor-in-Chief for Microphysiological Systems, and is an Associate Editor for Bio-Design and Manufacturing, Essays in Biochemistry, and Nano Select. He is also on the Editorial Board of Biofabrication, Bioprinting, Advanced Healthcare Materials, BMC Materials, and Chinese Chemical Letters, and Editorial Advisory Board of Heliyon and Biomicrofluidics, and Advisory Panel of Nanotechnology.